MarketCapTrends
ZVRA
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ · Healthcare

Zevra Therapeutics, Inc. Cash on Hand 2013–2025

Zevra Therapeutics, Inc. annual/quarterly cash on hand history from 2014 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Zevra Therapeutics, Inc. cash on hand for the quarter ending December 31, 2025 were 62.4M, a 84.72% increase year-over-year.
  • Zevra Therapeutics, Inc. cash on hand for 2025 were 62.4M, a 84.72% increase from 2024.
  • Zevra Therapeutics, Inc. cash on hand for 2024 were 33.8M, a 21.52% decrease from 2023.
  • Zevra Therapeutics, Inc. cash on hand for 2023 were 43.0M, a 34.24% decrease from 2022.
  • Zevra Therapeutics, Inc. cash on hand for 2022 were 65.5M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Zevra Therapeutics, Inc. Annual Cash on Hand (Millions of US $)
2025$62
2024$34
2023$43
2022$65
2021$112
2020$4
2019$3
2018$18
2015$32
2014$10
Zevra Therapeutics, Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$62
2024-12-31$34
2023-12-31$43
2022-12-31$65
2021-12-31$112
2020-12-31$4
2019-12-31$3
2018-12-31$18
2015-12-31$32
2014-12-31$10

Zevra Therapeutics, Inc. Cash on Hand — FAQ

Zevra Therapeutics, Inc. (ZVRA) cash on hand over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ZVRA's cash on hand history?

The chart and table above show Zevra Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.